TEMPO-1 – Talk Bio

Actionable Insights Powered by AI

AbbVie’s Tavapadon Shows Promising Results in Phase III Trial for Parkinson’s Disease

AbbVie, Tavapadon, Parkinson’s Disease, Phase III Trial, TEMPO-1, Cerevel Therapeutics